JAK2 and acquired polycythemia vera: Indeed, in the author’s experience, longevity appears to the rule in PV, rather than the exception, even in patients older than 60 years old [66]; in fact, one patient, who developed JAK2 exon 12-positive PV at the age of 17 years was alive and well at the age of 71 years, treated with phlebotomy alone.